15900.00EUR0.00%Mkt Cap: 80.20M EURP/E: 16.78Last update: 2026-05-14
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company's research services include compound management, and hi…
Industry Peers
Diagnostics & Researchloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)16.78
P/E (Forward)—
PEG3.26
P/B—
P/S2.06
EV/EBITDA—
EV/Revenue—
EPS (TTM)947.64
EPS (Forward)—
Cash Flow & Leverage
FCF Yield—
FCF Margin—
Operating CF—
CapEx (TTM)—
Net Debt/EBITDA-2.13
Net Debt-13.59M EUR
Technical
SMA 5016328.00 (-2.6%)
SMA 20017011.50 (-6.5%)
Beta0.03
S&P 52W Chg24.23%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)45.2
MACD-56.3561
MACD Signal-96.8791
MACD Hist.+40.5230
BB Upper15952.60 EUR
BB Middle15850.00 EUR
BB Lower15747.40 EUR
BB Width1.29%
ATR (14)43.85 EUR
Vol Ratio (20d)0.00x
52W Range
15400.0010% of range20600.00
52W High20600.00 EUR
52W Low15400.00 EUR
Profitability
Gross Margin53.49%
EBITDA Margin16.38%
Profit Margin11.67%
Oper. Margin5.70%
ROE6.25%
ROA5.37%
Revenue Growth-8.20%
Earnings Growth—
Balance Sheet
Debt/Equity0.00
Current Ratio8.28
Quick Ratio7.82
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateJul 27, 2017
Ownership
Shares Out.5.04K
Float—
Insiders95.78%
Institutions0.00%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap80.20M EUR
Enterprise Value—
Revenue (TTM)38.86M EUR
Gross Profit21.92M EUR
Net Income (TTM)4.78M EUR
Revenue/Share—
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees—
Last Price15900.00 EUR
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISIN—